Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action
Date
2022-08-26
Language
American English
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Cambridge University Press
Abstract
We examined risk associated with antibiotics used for Clostridioides difficile infection (CDI) at a single site from 2018 through 2020. Overall, 78 patients had nonrecurrent infections. Among inpatient antibiotics, intravenous meropenem had the highest CDI rate (3.56 per 1,000 days of therapy; n = 2 cases). Among outpatient antibiotics, metronidazole had the highest rate (0.071 per 1,000 pills dispensed; n = 3 cases).
Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Dysangco AT, Pierce TM, Bravata DM. Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action. Antimicrob Steward Healthc Epidemiol. 2022;2(1):e146. Published 2022 Aug 26. doi:10.1017/ash.2022.286
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Antimicrobial Stewardship & Healthcare Epidemiology
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
Version
Final published version